Table 1.
Baseline characteristics of the subjects
Protocol 1 (Cortisol) | Protocol 2 (Glucagon) | |||
---|---|---|---|---|
Subject Characteristics | No Diabetes (N = 17) | Type 2 Diabetes (N = 17) | No Diabetes (N = 21) | Type 2 Diabetes (N = 18) |
Age (years) | 61 ± 14 | 62 ± 20 | 58 ± 8 | 59 ± 12 |
Gender (M:F) | 9:8 | 9:8 | 11:10 | 11:7 |
Body mass index (kg/m2) | 30 ± 2 | 31 ± 3 | 29 ± 3 | 31 ± 3 |
Fat Free Mass (kg) | 55 ± 11 | 53 ± 9 | 54 ± 10 | 56 ± 10 |
HbA1c (%) mmol/mol | 5.3 ± 0.2/36 ± 2 | 7.6 ± 1.0/59 ± 12* | 5.3 ± 0.4/34 ± 4 | 7.2 ± 0.7/56 ± 8* |
Fasting plasma glucose (mg/dL) | 90 ± 5 | 161 ± 49* | 94 ± 8 | 146 ± 38* |
Data are mean ± standard deviation.
*P < 0.001 vs ND